Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Microbiol ; 197(3): 481-8, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25577256

ABSTRACT

Previously, we have shown that facultative pathogens Serratia grimesii and Serratia proteamaculans are capable to invade eukaryotic cells provided that they synthesize intracellular metalloprotease grimelysin or protealysin, respectively (Bozhokina et al. in Cell Biol Int 35(2):111-118, 2011). Noninvasive Escherichia coli transformed with grimelysin or protealysin gene became invasive, indicating that the protease is a virulence factor. Here we elucidated involvement of other virulence factors in the invasion of S. grimesii and S. proteamaculans. Under similar experimental conditions, the amount of S. proteamaculans internalized within human carcinoma HeLa cells was fivefold higher than that of S. grimesii. In accord with this, in S. proteamaculans, high activities of pore-forming hemolysin ShlA and extracellular metalloprotease serralysin were detected. In S. grimesii, activity of toxin ShlA was not detected, and the serralysin activity of the bacterial growth medium was very low. We also show that iron depletion strongly enhanced invasive activity of S. proteamaculans, increasing activities of hemolysin ShlA and serralysin, but did not affect S. grimesii properties. These results show that the invasive activity of S. proteamaculans is maintained, along with protealysin, by hemolysin and serralysin. On the other hand, grimelysin is so far the only known invasion factor of S. grimesii.


Subject(s)
Serratia Infections/microbiology , Serratia/pathogenicity , Escherichia coli/genetics , Extracellular Space/enzymology , HeLa Cells , Hemolysin Proteins/genetics , Hemolysin Proteins/metabolism , Humans , Iron/metabolism , Metalloendopeptidases/genetics , Metalloendopeptidases/metabolism , Serratia/genetics , Serratia Infections/enzymology , Species Specificity , Virulence Factors/genetics , Virulence Factors/metabolism
2.
Transplant Proc ; 41(8): 3253-5, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19857723

ABSTRACT

BACKGROUND: Serratia marcescens is an important pathogen in hospital infections since organisms resistant to multiple antimicrobials pose a special threat particularly among transplant patients. The aim of this work was to assess the number of strains producing beta-lactamases with extended spectrum (ESBL) among S. marcescens isolated from our patients. MATERIALS AND METHODS: We investigated S. marcescens isolated from 2005 to 2008 for ESBL. The phenotype methods were applied and additionally we chose strains for polymerase chain reactions using primers for the most popular types of ESBL. RESULTS: Over the investigated time, 257 patients were infected with S. marcescens with 188 (73%) displaying an ESBL-positive phenotype. A Molecular analysis showed that most of them produced both CTX-M and TEM beta-lactamases. In the last year, the percentage of ESBL-producing strains decreased, but also in the last year, we isolated S. marcescens resistant to carbapenems from three patients. CONCLUSIONS: The CTX-M type of ESBL predominated among ESBLs produced by strains of S. marcescens. The appearance of strains resistant to carbapenems is alarming.


Subject(s)
Anti-Bacterial Agents/pharmacology , Serratia Infections/genetics , Serratia marcescens/enzymology , Transplantation/adverse effects , beta-Lactamases/genetics , Anti-Bacterial Agents/therapeutic use , DNA Primers , Drug Therapy, Combination , Enterobacteriaceae/drug effects , Enterobacteriaceae/genetics , Enterobacteriaceae Infections/genetics , Humans , Polymerase Chain Reaction , Serratia Infections/drug therapy , Serratia Infections/enzymology , Serratia Infections/epidemiology , Serratia marcescens/genetics , Serratia marcescens/isolation & purification , beta-Lactamases/classification , beta-Lactamases/metabolism
3.
Int J Parasitol ; 38(5): 609-15, 2008 Apr.
Article in English | MEDLINE | ID: mdl-17950293

ABSTRACT

Animals and plants both respond rapidly to pathogens by inducing the expression of defence-related genes. Within this context, a prominent role has been assigned to the lysozyme. In the present study we isolated and carried out detailed analysis of the lysozyme gene in the plant nematode Meloidogyne artiellia. The expression of lysozyme was up-regulated following exposure of M. artiellia juveniles to the Gram-negative bacterium Serratia marcescens. On the other hand, when isolated eggs containing embryos at various developmental stages were challenged with bacteria, no increase in lysozyme expression was detected. Evidence of lysozyme expression regulation was obtained in the case of adult male and females worms collected from soil. The lysozyme gene was expressed solely in the nematode intestine and, as it is predicted to be secreted, may protect the nematode from microbial infections originating in the intestinal lumen or in the pseudocoelom. This paper demonstrates, to our knowledge for the first time, the immune response to infection in a plant parasitic nematode.


Subject(s)
Muramidase/metabolism , Serratia Infections/immunology , Serratia marcescens , Tylenchoidea/enzymology , Amino Acid Sequence , Animals , Female , Gene Expression Regulation, Enzymologic , Immunity, Innate , Intestines/enzymology , Intestines/immunology , Male , Molecular Sequence Data , Muramidase/genetics , Plants/parasitology , Sequence Alignment , Sequence Homology, Amino Acid , Serratia Infections/enzymology , Tylenchoidea/genetics , Tylenchoidea/immunology , Up-Regulation
4.
Arch Insect Biochem Physiol ; 52(1): 1-6, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12489129

ABSTRACT

Intracellular phospholipase A(2) (PLA(2)) is responsible for releasing arachidonic acid from cellular phospholipids, and is thought to be the first step in eicosanoid biosynthesis. Intracellular PLA(2)s have been characterized in fat body and hemocytes from tobacco hornworms, Manduca sexta. Here we show that bacterial challenge stimulated increased PLA(2) activity in isolated hemocyte preparations, relative to control hemocyte preparations that were challenged with water. The increased activity was detected as early as 15 s post-challenge and lasted for at least 1 h. The increased activity depended on a minimum bacterial challenge dose, and was inhibited in reactions conducted in the presence of oleyoxyethylphosphorylcholine, a site-specific PLA(2) inhibitor. In independent experiments with serum prepared from whole hemolymph, we found no PLA(2) activity was secreted into serum during the first 24 h following bacterial infection. We infer that a hemocytic intracellular PLA(2) activity is increased immediately an infection is detected. The significance of this enzyme lies in its role in launching the biosynthesis of eicosanoids, which mediate cellular immune reactions to bacterial infection.


Subject(s)
Eicosanoids/immunology , Manduca/enzymology , Manduca/immunology , Phospholipases A/metabolism , Phosphorylcholine/analogs & derivatives , Serratia Infections/enzymology , Animals , Arachidonic Acid/metabolism , Eicosanoids/biosynthesis , Hemocytes/enzymology , Hemocytes/metabolism , Hemolymph/enzymology , Hydrolysis , Manduca/microbiology , Phospholipases A/antagonists & inhibitors , Phospholipases A2 , Phosphorylcholine/pharmacology , Serratia Infections/immunology , Serratia Infections/metabolism , Serratia marcescens , Time Factors
5.
Antimicrob Agents Chemother ; 42(1): 190-3, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9449286

ABSTRACT

The sequence of the DNA gyrase gyrA gene of Serratia marcescens ATCC 14756 was determined. An open reading frame of 2,640 nucleotides coding for a polypeptide with a calculated molecular mass of 97,460 was found, and its sequence complemented the sequence of an Escherichia coli gyrA temperature-sensitive mutation. Analysis of the PCR products of the quinolone resistance-determining regions of gyrA genes from six quinolone-resistant clinical isolates revealed a single amino acid substitution, Ser-83 to Arg or Asp-87 to Tyr, in all six mutants, suggesting that a mutational alteration in gyrA is a common mechanism of quinolone resistance in S. marcescens.


Subject(s)
DNA Topoisomerases, Type II/genetics , Serratia Infections/genetics , Serratia marcescens/genetics , 4-Quinolones , Amino Acid Sequence , Anti-Infective Agents/therapeutic use , Base Sequence , Cloning, Molecular , DNA Gyrase , Drug Resistance, Microbial/genetics , Humans , Molecular Sequence Data , Point Mutation , Serratia Infections/drug therapy , Serratia Infections/enzymology , Serratia marcescens/drug effects , Serratia marcescens/enzymology , Topoisomerase II Inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...